In:
Genes, Chromosomes and Cancer, Wiley, Vol. 51, No. 1 ( 2012-01), p. 42-53
Kurzfassung:
In this study, we established and analyzed a novel human myeloid leukemia cell line, AMU‐AML1, from a patient with acute myeloid leukemia with multilineage dysplasia before the initiation of chemotherapy. AMU‐AML1 cells were positive for CD13, CD33, CD117, and HLA‐DR by flow cytometry analysis and showed a single chromosomal abnormality, 46, XY, t(12;22)(p13;q11.2), by G‐banding and spectral karyotyping. Fluorescent in situ hybridization analysis indicated that the chromosomal breakpoint in band 12p13 was in the sequence from the 5′ untranslated region to intron 1 of TEL and that the chromosomal breakpoint in band 22q11 was in the 3′ untranslated region of MN1. The chimeric transcript and protein of MN1‐TEL could not be detected by reverse‐transcriptase polymerase chain reaction or Western blot analysis. However, the MN1 gene was amplified to three copies detected by array comparative genomic hybridization analysis, and the expression levels of the MN1 transcript and protein were high in AMU‐AML1 cells when compared with other cell lines with t(12;22)(p13;q11‐12). Our data showed that AMU‐AML1 cells contain t(12;22)(p13;q11.2) without chimeric fusion of MN1 and TEL . The AMU‐AML1 cells gained MN1 copies and had high expression levels of MN1. Thus, the AMU‐AML1 cell line is useful for studying the biological consequences of t(12;22)(p13;q11.2) lacking chimeric MN1‐TEL . © 2011 Wiley Periodicals, Inc.
Materialart:
Online-Ressource
ISSN:
1045-2257
,
1098-2264
Sprache:
Englisch
Verlag:
Wiley
Publikationsdatum:
2012
ZDB Id:
1018988-9
ZDB Id:
1492641-6
SSG:
12
